Life Expectancy Statistics in Norway 2026 | Key Facts

Life Expectancy in Norway 2026

Norway consistently ranks among the countries with the longest-living populations on earth, and its life expectancy statistics in 2026 continue to reflect a nation that has, over several generations, built one of the most effective public health systems in the world. Life expectancy at birth is the number of years a newborn can be expected to live given the mortality conditions prevailing at the time of birth — and in Norway, that number sits comfortably above 83 years, a figure that places the country well above both the OECD average of 81.1 years and the global average of approximately 73.7 years. This remarkable longevity is not the product of a single policy or geographic advantage but the cumulative outcome of universal healthcare access, a comprehensive social welfare system, low poverty rates, relatively clean living environments, and decades of sustained public investment in prevention and early treatment. Statistics Norway (SSB), the country’s official national statistics body, tracks life expectancy data continuously, providing one of the most reliable and long-running demographic records in the world — dating back to 1735 for national mortality figures.

What makes Norway’s life expectancy story particularly instructive in 2026 is how the country has navigated the post-pandemic recovery. Life expectancy dipped in 2022 due to a surge in COVID-19-related deaths, falling from 82.8 years in 2021 to 82.5 years in 2022 — but it rebounded sharply, crossing 83.3 years in 2024, which was 0.3 years above Norway’s own pre-pandemic level, according to the OECD/EU Country Health Profile 2025. This recovery speed itself speaks to systemic resilience. Norway’s universal single-payer healthcare model — the Folketrygden national insurance scheme — ensures that every resident has access to a core set of health services regardless of income, geography, or employment status, which means health shocks do not translate into catastrophic financial exposure that in other countries drives delayed care and premature death. Understanding the full picture of life expectancy statistics in Norway 2026 — broken down by sex, age, cause of death, geography, income, and healthcare investment — is essential context for anyone studying Nordic public health, comparative demography, or the policy drivers behind exceptional population longevity.

Interesting Key Facts — Life Expectancy in Norway 2026

All statistics in the table below are sourced exclusively from Statistics Norway (SSB), the OECD, WHO, Eurostat, Nordic Statistics, the Norwegian Institute of Public Health (Folkehelseinstituttet), and peer-reviewed scientific literature. Every figure is traceable to a primary institutional source.

Data Sources: Statistics Norway (SSB) Deaths Table, January 2026 release; OECD Health at a Glance 2025 — Norway Country Note; OECD/EU State of Health in the EU — Norway Country Health Profile 2025; Nordic Statistics Nordic Life Expectancy Report September 2025; UN World Population Prospects 2024; WHO Global Health Estimates 2024; Folkehelseinstituttet (Norwegian Institute of Public Health) Cause of Death Registry; IHME Global Burden of Disease Study 2019 — Norway Analysis

Norway’s life expectancy facts paint the portrait of a society that has made an exceptionally successful long-term investment in the conditions that sustain human longevity. The headline figure — 83.3 years in 2024, rising to an estimated 83.6 years in 2025 — sits nearly 10 full years above the global average, a gap that reflects the cumulative advantage of universal healthcare, high incomes, low inequality, clean air and water, strong social safety nets, and a culture that historically has had lower rates of harmful behaviours like smoking and heavy alcohol consumption than most European peers. The fact that Norway’s smoking rate is 63% below the EU average and alcohol consumption 33% below the EU average is not incidental — both are leading modifiable risk factors for cardiovascular disease and cancer, the two causes that together account for approximately 60% of all Norwegian deaths.

The infant mortality rate of just 1.65 deaths per 1,000 live births in 2024 is among the lowest ever recorded anywhere in the world — and the historical context makes this even more striking: in 1840, Norway’s infant mortality rate exceeded 140 per 1,000 births, meaning the country has reduced infant mortality by roughly 99% over 185 years. The gender gap of approximately 3 years — with Norwegian women living to 84.63 years and men to 81.59 years on average in 2024 (SSB data) — is broadly consistent with biological and behavioural patterns seen across all high-income countries, though it has been gradually narrowing over recent decades. The income inequality dimension is the most uncomfortable fact in the table: even in one of the world’s most egalitarian societies, the richest 1% of Norwegian men live 8.4 years longer than the poorest 1%, while for women that gap widens to 13.8 years — a reminder that economic position, even in a generous welfare state, remains a powerful determinant of how long people actually live.

Norway Life Expectancy by Sex Over Time in 2026

Tracking Norway’s life expectancy trends by sex over recent decades reveals both the progress made and the persistent biological and behavioural gap that keeps men’s and women’s outcomes meaningfully different. Data below draws from Statistics Norway (SSB) official life tables and the Nordic Statistics cross-country report published in September 2025.

Data Sources: Statistics Norway (SSB) Deaths and Life Expectancy Table 05375, January 2026 update; Nordic Statistics Nordic Life Expectancy Report, September 2025; OECD/EU Norway Country Health Profile 2025; UN World Population Prospects 2024; Life in Norway, September 2024 analysis

The long-run trajectory of Norwegian life expectancy is one of the most consistent stories in global public health. From 75.6 years combined in 1980 to 83.3 years in 2024, Norway added nearly 8 full years to average life expectancy in four decades — a pace sustained by the progressive elimination of infectious disease mortality, the near-collapse of cardiovascular disease death rates, and improvements in cancer treatment survival. The gender gap, once approximately 7 years in 1980, has narrowed to around 3 years by 2024, primarily because Norwegian men have made disproportionately large gains over this period, driven by sharp reductions in smoking-related cardiovascular deaths and improved occupational safety outcomes. Norwegian women’s life expectancy, while also growing, started from a higher baseline and has advanced more gradually.

The COVID-19 dip in 2022 — from 83.3 years in 2021 to 82.51 years — was significant but temporary. Norway’s recovery by 2024 to 83.3 years, surpassing the pre-pandemic level of 83.0 years, illustrates the speed at which a well-resourced health system can absorb and recover from demographic shocks. Notably, men’s life expectancy fell more sharply in 2022 (to 80.9 years) than women’s (to 84.4 years), reflecting men’s higher COVID-19 mortality risk globally — a pattern consistent with findings across all OECD countries during that period. The SSB data released in January 2026 confirms the full recovery of both trajectories.

Norway Life Expectancy vs. Nordic Countries in 2026

Norway’s life expectancy performance sits solidly in the middle of the Nordic cluster — a group of countries that collectively define the global frontier for population health. The comparison below uses the most recent verified data from the Nordic Statistics joint report published September 2025.

Data Sources: Nordic Statistics — Nordic Life Expectancy Report September 30, 2025; OECD Health at a Glance 2025 — Norway Country Note November 2025; OECD/EU State of Health in the EU Norway Country Health Profile 2025; World Economics Life Expectancy Data 2025

Within the Nordic context, Norway’s 83.3-year life expectancy in 2024 places it solidly in the middle of a cluster of nations that together represent the world’s highest sustained life expectancy. Sweden’s 84.1 years leads the group — a margin of 0.8 years that researchers attribute to Sweden’s marginally lower cardiovascular death rates and historically higher rates of physical activity. Denmark’s 82.3 years, at the bottom of the Nordic table, remains the most studied anomaly in Nordic health research; its historically higher rates of smoking and alcohol consumption account for much of the gap, though Denmark has made significant gains in recent years. The Nordic region collectively exceeded its pre-pandemic life expectancy average of 83.2 years in 2024 for the first time — a milestone reported by Nordic Statistics in September 2025 — confirming that the entire region has moved beyond COVID-19’s demographic shadow.

Norway’s positioning in this group reflects both genuine strengths and areas of ongoing attention. Its obesity rate — now affecting 1 in 6 adults — and the rapid rise in snus (tobacco pouch) use among young people, with 25% of men aged 16–24 using snus daily in 2022, are the risk factors most closely watched by public health officials. Snus, while generally considered less acutely lethal than cigarettes, carries long-term cardiovascular and cancer risks that could modestly suppress future life expectancy gains if adoption remains this high in younger cohorts. These are the dynamics that explain why Norway, despite its exceptional overall performance, is not at the very top of the Nordic table — and they are the same dynamics that public health policy in Norway is actively attempting to address through youth prevention campaigns and nicotine product regulation.

Norway Life Expectancy by Cause of Death in 2026

Understanding which diseases take the most Norwegian lives — and how those patterns have shifted over time — is central to interpreting life expectancy trends in Norway and the policy challenges ahead.

Data Sources: Statista / Folkehelseinstituttet (Norwegian Institute of Public Health) Cause of Death Registry 2024; Statistics Norway (SSB) Deaths Data January 2026; OECD/EU Norway Country Health Profile 2025 (published December 2025); SSB archived cause of death analyses

Cancer has overtaken cardiovascular disease as Norway’s leading cause of death, a shift that is partly good news and partly a reflection of demographic realities. The reason cancer now kills more Norwegians than heart disease is that cardiovascular mortality has fallen dramatically over recent decades — driven by better emergency care, widespread statin use, lower smoking rates, and improved surgical interventions — while cancer mortality has declined more slowly. More than 60% of cancer deaths in Norway occur in people under 80, compared to 70% of cardiovascular deaths occurring in people over 80 — making cancer the primary driver of years of life lost prematurely. This explains why Norwegian public health researchers consistently identify cancer as the main cause of reduced life expectancy rather than simply the leading cause of death in raw numbers.

The gender dimension of cause-of-death data in Norway is striking. Men have an age-standardised cancer incidence rate 28% higher than women and a CVD death rate from ischaemic heart disease more than double that of women — 56 per 100,000 versus 25 per 100,000 in 2023. These disparities feed directly into the 3-year life expectancy gap between Norwegian men and women and explain much of why men’s longevity gains, while impressive, consistently lag behind women’s. Prostate cancer accounting for over 30% of new male cancer cases and breast cancer accounting for 26% of new female cancer cases in 2022 represent the two most prevalent cancer burdens by sex, and both are areas where Norway has invested heavily in screening infrastructure and treatment capacity. With Norway’s population ageing and its median age now at 40.9 years, the incidence of age-related cancers and dementia will continue to rise — the primary future challenge for a health system that has largely solved the diseases of earlier life.

Norway Healthcare System & Life Expectancy Drivers in 2026

The strength and structure of Norway’s healthcare system is the single most important institutional factor behind the country’s exceptional life expectancy outcomes. The data below draws from the OECD Health at a Glance 2025, the OECD/EU Norway Country Health Profile 2025, and the Norwegian Institute of Public Health.

Data Sources: OECD Health at a Glance 2025 — Norway Country Note (November 2025); OECD/EU State of Health in the EU Norway Country Health Profile 2025 (December 2025); BMC Medicine — Forecasting Norwegian Health Expenditures 2022–2050 (February 2025); WHO Global Health Estimates 2024

The numbers in the table above reveal the structural backbone of Norway’s exceptional life expectancy. With 5.0 doctors per 1,000 population — compared to the OECD average of 3.9 — and 15.6 nurses per 1,000 against an OECD average of just 9.2, Norway has invested heavily in frontline clinical capacity that translates directly into better access, faster diagnosis, and more effective treatment. The consequence is visible in outcome data that is even more striking than the workforce numbers: Norway’s preventable mortality of 105 per 100,000 is 34% below the OECD average of 158, and its treatable mortality of 51 per 100,000 is 35% below the OECD average of 79. These are the figures that matter most when assessing healthcare quality — they represent lives that were saved because the system caught diseases early, managed chronic conditions effectively, and delivered acute care without significant delay or financial obstruction. That only 0.9% of Norway’s population reports unmet healthcare needs — against an OECD average of 2.3% — is a direct product of universal coverage and low financial barriers.

The 86% of health spending covered through mandatory public financing and the 14% out-of-pocket cost share (below the OECD average of 18%) reflect a system deliberately designed to remove economic deterrents to care-seeking. In Norway, a person does not delay seeing a doctor because they cannot afford the visit — and that structural fact, multiplied across millions of interactions over decades, compounds into measurably longer lives. The forecast that healthcare spending will rise from 10.6% of GDP in 2022 to 14.3% by 2050, driven primarily by population ageing and rising chronic disease prevalence, represents Norway’s central public finance challenge for the coming generation. How it manages that transition — maintaining quality and access while controlling cost growth — will determine whether today’s exceptional life expectancy statistics can be sustained and extended for the Norwegians born in the decades ahead.

Norway Life Expectancy by Income & Education in 2026

Even within one of the world’s most equal societies, life expectancy in Norway is not distributed evenly across socioeconomic groups. The research data below — drawn from peer-reviewed studies using Norwegian population registers and the IHME Global Burden of Disease analysis — quantifies the health gap that persists despite Norway’s generous welfare state.

Data Sources: IHME Global Burden of Disease Study 2019 — Norway Country Analysis (published 2022); BMC Public Health — Inequality in Quality-Adjusted Life Expectancy by Educational Attainment in Norway (2023); PMC — Geographic Health Inequalities in Norway: Gini Analysis (2018); JAMA — Association of Household Income with Life Expectancy in Norway 2005–2015 (2019)

The socioeconomic gradient in Norwegian life expectancy is one of the most carefully studied examples in public health precisely because it exists within what should theoretically be the most favourable conditions for equality: universal healthcare with minimal co-payments, one of the world’s most generous unemployment and social support systems, free tertiary education, and relatively compressed income inequality by global standards. Yet the 8.4-year male and 13.8-year female life expectancy gap between the richest and poorest 1% of Norwegians confirms that economic position still exerts powerful independent effects on longevity even when healthcare access is formally equalised. The mechanisms are not hard to identify: higher income brings better housing, lower stress, healthier diet, more leisure time for physical activity, and social environments with lower exposure to violence and addiction. These are factors that no healthcare system alone can fully offset.

The geographic dimension of inequality has been narrowing consistently. The Gini index for life expectancy across Norwegian counties fell from 0.43 in 1980 to 0.32 in 2014, reflecting decades of active regional policy that attempted to maintain comparable health infrastructure and socioeconomic conditions across a country with a very dispersed population. The convergence of Oslo’s male life expectancy from just 71.9 years in 1990 to 81.3 years in 2019 — nearly matching the national average after decades of urban deprivation effects — is one of the clearest examples of this trend. The far north county of Troms og Finnmark retains the highest years-of-life-lost rate compared to the national average, reflecting persistent geographic, demographic, and economic disadvantages in Norway’s most remote region. Halving the probability of dying before age 70 — from 26% in 1980 to 14% in 2014 — represents perhaps the single most dramatic improvement in Norwegian mortality over recent decades and is the most concrete expression of how the system’s overall trajectory has benefited every segment of the population, even if inequality at the extremes persists.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE